Study of Oxytocin in Autism Reciprocal Social Behaviors (SOARS-B)

This study is sponsored by Eunice Kennedy Shriver Institute for Child Health and Human Development.

A research team at The Duke Center for Autism and Brain Development is currently conducting a research study involving children (ages 3-17 years) with a diagnosis of an autism spectrum disorder. The study is looking at an investigational medication called oxytocin. Oxytocin is thought to improve social functioning in individuals with autism. Oxytocin is administered in the form of a nasal spray. Participants will take fake medication (placebo) or active medication (oxytocin) for 6 months. After the initial 6 months, everyone will get to try the real medication (oxytocin). The study involves monthly visits to The Duke Center for Autism and Brain Development. Thinking tests, physical exams, and blood tests are involved. Participants will be provided with free and convenient parking. Research related services and medication will be free of charge. Participants will be compensated for their participation.

For more information call 1-888-691-1062 or email autismresearch@dm.duke.edu.

Click here to download a study brochure.
 

Criteria
Children ages 3-17 with a diagnosis of an autism spectrum disorder are being recruited for this study.
Enrollment status
Completed